Free CHA2DS2-Vasc Calculator

CHA2DS2-VASc: Quantifying Stroke Risk in Atrial Fibrillation

Atrial fibrillation (AFib) is the most prevalent sustained cardiac arrhythmia and a major contributor to ischemic stroke. The CHA2DS2-VASc score has become the standard clinical scale for evaluating thromboembolic risk in patients with non-valvular AFib, directly supporting anticoagulation decisions. By systematically scoring seven independent stroke risk factors, this tool provides a reproducible estimate of annual stroke and systemic embolism risk. Its integration into routine practice helps clinicians identify patients who will benefit most from oral anticoagulation while sparing low‑risk individuals from unnecessary bleeding hazards.

Developed in 2010 and endorsed by the American Heart Association and other cardiology societies, the CHA2DS2‑VASc scale refines the earlier CHADS2 system. It adds female sex, an intermediate age category (65–74 years), and a formalized vascular disease component, thereby improving risk discrimination—especially for patients with only one or two prior risk factors. Ongoing research continues to probe whether conditions such as obstructive sleep apnea should also be included, but the current seven‑factor model remains the foundation of AFib stroke risk assessment.

Scoring Components

The acronym describes each risk factor; points accumulate as detailed below. A CHA2DS2‑VASc calculator (often available as an online stroke risk calculator for AFib) converts these inputs into a total score from 0 to 9.

• C – Congestive heart failure (1 point): Present when signs/symptoms (e.g., dyspnea, edema) are accompanied by objective evidence such as reduced left ventricular ejection fraction on echocardiography.
• H – Hypertension (1 point): Documented resting blood pressure >140/90 mmHg on at least two occasions, or ongoing antihypertensive treatment.
• A₂ – Age ≥75 years (2 points).
• D – Diabetes mellitus (1 point): Receiving insulin or oral antidiabetic agents, or a fasting plasma glucose >125 mg/dL (7 mmol/L). Often coexists with elevated hemoglobin A1c.
• S₂ – Prior stroke, transient ischemic attack (TIA), or thromboembolism (2 points). A previous event of this kind signals a particularly high risk.
• V – Vascular disease (1 point): History of myocardial infarction, peripheral artery disease, or documented aortic plaque.
• A – Age 65–74 years (1 point).
• Sc – Sex category (female) (1 point). Applicable only when at least one other stroke risk factor is present; isolated female sex does not alter the score.

Using the CHA2DS2‑VASc Calculator

Operating the calculator is straightforward: the user selects all risk factors that apply to the patient. The tool instantly computes the total score and typically displays corresponding annual risk estimates and a brief anticoagulation recommendation. No manual arithmetic is needed. Because many of the same factors also predict major bleeding, it is prudent to simultaneously evaluate the HAS‑BLED score. Controlling modifiable factors (e.g., hypertension, heart failure) can lower both thrombotic and hemorrhagic risks.

Risk Stratification Data

The Swedish Atrial Fibrillation cohort study provides the most widely cited yearly event rates for each score level:

CHA2DS2‑VASc Score	Ischemic Stroke Risk (%)	Stroke / TIA / Peripheral Embolism Risk (%)
0	0.2	0.3
1	0.6	0.9
2	2.2	2.9
3	3.2	4.6
4	4.8	6.7
5	7.2	10.0
6	9.7	13.6
7	11.2	15.7
8	10.8	15.2
9	12.23	17.4

Interpretation and Anticoagulation Guidance

Although the score measures a wide range of risk, treatment guidelines organize patients into three broad categories:

• Score 0 (or 1 for female when it is the only risk factor) – Low risk: Oral anticoagulation is not routinely suggested. The very low event rate makes the bleeding risk of therapy unacceptable.
• Score 1 in male – Moderate risk: Anticoagulation should be considered after weighing clinical and patient factors.
• Score ≥2 – High risk: Oral anticoagulation is recommended (e.g., vitamin K antagonists or direct oral anticoagulants), provided no strong contraindications exist.

These recommendations are not absolute; individual clinical judgment, patient preferences, and bleeding risk always override any calculated score. A thorough history and physical examination remain essential, especially when only one risk factor is present, because the severity of that factor may vary.

Clarifying the Nomenclature

You may encounter terms such as “CHADSVasc calculator” or “CHADSVasc score.” These refer to the same CHA2DS2‑VASc scale described here. The older CHADS (or CHADS2) system considered only five risk factors (congestive heart failure, hypertension, age ≥75, diabetes, and prior stroke/TIA) and had a maximum of 6 points; its limited ability to stratify lower‑risk patients prompted the 2010 update. The superscript “2” in the name highlights the two elements (age ≥75 and prior stroke/TIA) that carry 2 points instead of 1, making the acronym easier to remember. With modern online tools, the manual memorization of point values is no longer necessary.

Important Caveats

No risk calculator can replace a physician’s comprehensive assessment. Before prescribing any anticoagulant, verify dosing, contraindications, and renal or hepatic function. The CHA2DS2‑VASc scale was validated primarily for non‑valvular AFib; its performance in other conditions (e.g., sick sinus syndrome) is less established. The tool provides probabilistic estimates, not certainties, and should always be used alongside clinical reasoning and patient dialogue.